Yamada H, Matsumoto S, Matsumoto T, Yamada T, Yamashita U
Jpn J Cancer Res. 2000; 91(5):534-42.
PMID: 10835499
PMC: 5926379.
DOI: 10.1111/j.1349-7006.2000.tb00978.x.
Suk K, Somers S, Erickson K
Immunology. 1993; 80(4):617-24.
PMID: 8307612
PMC: 1422257.
Shin J, Park J, Kim J, Lee J, Kim S
Clin Exp Immunol. 1995; 100(1):26-31.
PMID: 7697918
PMC: 1534268.
DOI: 10.1111/j.1365-2249.1995.tb03599.x.
Mannel D, Falk W, Meltzer M
Infect Immun. 1981; 33(1):156-64.
PMID: 7021422
PMC: 350670.
DOI: 10.1128/iai.33.1.156-164.1981.
Freedman V, Calvelli T, Silagi S, Silverstein S
J Exp Med. 1980; 152(3):657-73.
PMID: 6997425
PMC: 2185920.
DOI: 10.1084/jem.152.3.657.
Conversion of soluble immune response suppressor to macrophage-derived suppressor factor by peroxide.
Aune T, Pierce C
Proc Natl Acad Sci U S A. 1981; 78(8):5099-103.
PMID: 6975476
PMC: 320340.
DOI: 10.1073/pnas.78.8.5099.
Binding of bacillus Calmette-Guérin-activated macrophages to tumor targets. Selective inhibition by membrane preparations from homologous and heterologous neoplastic cells.
Marino P, Whisnant C, Adams D
J Exp Med. 1981; 154(1):77-87.
PMID: 6788893
PMC: 2186396.
DOI: 10.1084/jem.154.1.77.
Bacillus Calmette-Guérin-activated murine macrophages kill syngeneic melanoma cells under strict anaerobic conditions.
Freedman V, Gorrell T, Nathan C, Copeland C, Silverstein S
J Exp Med. 1984; 160(1):94-107.
PMID: 6736873
PMC: 2187428.
DOI: 10.1084/jem.160.1.94.
In vitro suppression of T-cell mitogenic response and tumor cell proliferation by spleen macrophages from normal chickens.
Sharma J
Infect Immun. 1980; 28(3):914-22.
PMID: 6447112
PMC: 551038.
DOI: 10.1128/iai.28.3.914-922.1980.
Macrophage antiviral activity: extrinsic versus intrinsic activity.
Stohlman S, Woodward J, Frelinger J
Infect Immun. 1982; 36(2):672-7.
PMID: 6282756
PMC: 351282.
DOI: 10.1128/iai.36.2.672-677.1982.
Detection of either rapidly cytolytic macrophages or NK cells in "activated" peritoneal exudates depends on the method of analysis and the target cell type.
GRAY J, Brooks C, Baldwin R
Immunology. 1981; 42(4):561-8.
PMID: 6263794
PMC: 1458269.
Resistance of simian virus 40-transformed hamster cells to the cytolytic effect of activated macrophages: a possible factor in species-specific viral oncogenicity.
Cook J, Hibbs Jr J, Lewis Jr A
Proc Natl Acad Sci U S A. 1980; 77(11):6773-7.
PMID: 6256760
PMC: 350371.
DOI: 10.1073/pnas.77.11.6773.
Rate and efficiency of complement-dependent phagocytosis in cytolytic and non-cytolytic inflammatory macrophages.
Norin A, de Pinho R
Immunology. 1986; 58(4):561-8.
PMID: 3733155
PMC: 1453111.
Infection of DBA/2 or C3H/HeJ mice by intraperitoneal injection of vaccinia virus elicits activated macrophages, cytolytic and cytostatic for S91-melanoma tumor cells.
Natuk R, Byrne J, Holowczak J
Cancer Immunol Immunother. 1986; 22(3):197-203.
PMID: 3731205
PMC: 11038435.
DOI: 10.1007/BF00200033.
Potentiation of antitumor activity of macrophages by recombinant interferon alpha A/D contained in gelatin microspheres.
Tabata Y, Uno K, Ikada Y, Muramatsu S
Jpn J Cancer Res. 1988; 79(5):636-46.
PMID: 3136117
PMC: 5917552.
DOI: 10.1111/j.1349-7006.1988.tb00034.x.
Macrophage-resistant murine simian virus 40 tumors express a retroviral type-specific gp70.
Chapes S, ONeill A, Flaherty L, Gooding L
J Virol. 1987; 61(3):928-32.
PMID: 3027416
PMC: 254041.
DOI: 10.1128/JVI.61.3.928-932.1987.
Activated macrophages release a factor which lyses malignant cells but not normal cells.
CURRIE G, Basham C
J Exp Med. 1975; 142(6):1600-5.
PMID: 1194858
PMC: 2190066.
DOI: 10.1084/jem.142.6.1600.
Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.
Nathan C, Brukner L, Silverstein S, COHN Z
J Exp Med. 1979; 149(1):84-99.
PMID: 368287
PMC: 2184749.
DOI: 10.1084/jem.149.1.84.
Antitumor activity of Listeria monocytogenes on a guinea pig fibrosarcoma.
Dustoor M, Fulton A, Croft W, Blazkovec A
Infect Immun. 1979; 23(1):54-60.
PMID: 106006
PMC: 550689.
DOI: 10.1128/iai.23.1.54-60.1979.